16 Jan 2026
Sleep apnea isn't just about snoring-it's a major heart risk. Untreated, it spikes blood pressure, triggers dangerous heart rhythms like atrial fibrillation, and increases stroke and heart failure risk. Treatment with CPAP can reverse much of the damage.
15 Jan 2026
New U.S. House rules from 2023-2025 require strict electronic filing, committee approval, and classification of amendment substitutions. These changes boosted efficiency but reduced minority input, sparking debate over fairness and democracy in lawmaking.
14 Jan 2026
Combining tizanidine and ciprofloxacin can cause dangerous drops in blood pressure and extreme drowsiness due to a powerful drug interaction. Learn why this combo is risky and what to do instead.
13 Jan 2026
Quercetin supplements can interfere with how your body processes medications, raising drug levels and increasing side effect risks. Learn which meds are most affected and what to do to stay safe.
12 Jan 2026
Recognize the hidden signs of pediatric medication overdose-from opioids to acetaminophen-and know exactly when to call Poison Control or 911. Early action saves lives.
11 Jan 2026
Bioequivalent medications are generic drugs proven to work the same as brand-name versions in the body. Learn how regulators test for equivalence, when it matters, and what you should know before switching.
10 Jan 2026
Learn how medicines interact with your body at a molecular level and why understanding their mechanism is the key to using them safely - and avoiding dangerous side effects.
9 Jan 2026
Serotonin syndrome is a dangerous reaction to antidepressant overdose or drug interactions. Learn the early warning signs - like tremors and clonus - and what to do before it becomes life-threatening.
8 Jan 2026
Common medications like Benadryl and oxybutynin can build up anticholinergic burden in older adults, increasing dementia risk. Learn which drugs are dangerous, how they affect the brain, and what safer alternatives exist.
7 Jan 2026
180-day exclusivity under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges. But delays in market entry can block competition for years, keeping prices high for patients.
